MoneyWorks4Me

Dr. Lal PathLabs informs about analyst meet

17 Mar 2023 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that it enclosed the details of proposed schedule of Analyst/ Institutional Investor meeting(s).

The above information is a part of company’s filings submitted to BSE.

Peers